Inhibitory Effect of Bone Morphogenetic Protein 4 in Retinal Pigment Epithelial-Mesenchymal Transition

被引:0
作者
Haipei Yao
Hui Li
Shuai Yang
Min Li
Chun Zhao
Jingfa Zhang
Guotong Xu
Fang Wang
机构
[1] Shanghai Tenth People’s Hospital,Department of ophthalmology
[2] Tongji University,undefined
[3] School of Medicine,undefined
[4] Tongji Eye Institute,undefined
[5] Tongji University School of Medicine,undefined
来源
Scientific Reports | / 6卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Proliferative vitreoretinopathy (PVR), a serious vision-threatening complication of retinal detachment (RD), is characterized by the formation of contractile fibrotic membranes, in which epithelial-mesenchymal transition (EMT) of the retinal pigment epithelium (RPE) is a major event. Recent studies suggest an important role of bone morphogenetic protein 4 (BMP4) in the suppression of fibrosis. In this study, we aimed to investigate the role of BMP4 in the pathological process of PVR, particularly in the EMT of RPE cells. We found that BMP4 and its receptors were co-labelled with cytokeratin and α-SMA positive cells within the PVR membrane. Moreover, the mRNA and protein expression levels of BMP4 were decreased whereas BMP4 receptors ALK2, ALK3 and ALK6 were increased during TGF-β-induced EMT in primary RPE cells. Exogenous BMP4 inhibited TGF-β-induced epithelial marker down-regulation, as well as mesenchymal marker up-regulation at both the mRNA and protein levels in RPE cells. In addition, BMP4 treatment attenuated the TGF-β-induced gel contraction, cell migration and Smad2/3 phosphorylation. However, knockdown of endogenous BMP4 stimulated changes in EMT markers. Our results confirm the hypothesis that BMP4 might inhibit TGF-β-mediated EMT in RPE cells via the Smad2/3 pathway and suppress contraction. This might represent a potential treatment for PVR.
引用
收藏
相关论文
共 90 条
[1]  
Pastor JC(2002)Proliferative vitreoretinopathy: risk factors and pathobiology Prog Retin Eye Res. 21 127-144
[2]  
de la Rua ER(2008)Vitreous proteomic analysis of proliferative vitreoretinopathy Proteomics. 8 3667-3678
[3]  
Martin F(1991)Immunocytology of cellular components in vitreous and subretinal fluid from patients with proliferative vitreoretinopathy Ophthalmologica. 203 38-46
[4]  
Yu J(1999)Epithelial-mesenchymal transition in proliferative vitreoretinopathy: intermediate filament protein expression in retinal pigment epithelial cells Invest Ophthalmol Vis Sci. 40 2062-2072
[5]  
Baudouin C(1991)Cytokines in proliferative vitreoretinopathy Eye (Lond). 5 686-693
[6]  
Casaroli-Marano RP(2014)Signaling mechanisms of the epithelial-mesenchymal transition Sci Signal 7 8-1428
[7]  
Pagan R(2009)The basics of epithelial-mesenchymal transition J Clin Invest. 119 1420-329
[8]  
Vilaro S(2011)Snail involves in the transforming growth factor beta1-mediated epithelial-mesenchymal transition of retinal pigment epithelial cells PLoS One 6 322-461
[9]  
Limb GA(1992)Decapentaplegic acts as a morphogen to organize dorsal-ventral pattern in the Drosophila embryo Cell 71 451-899
[10]  
Gonzalez DM(1965)Bone: formation by autoinduction Science 150 893-2807